Back to search

Massachusetts Institute of Technology

Macrophage-mediated resistance mechanisms against MAPK inhibitory by cancer therapeutics

Abstract

dc:description.abstract

Kinase inhibitors targeting the MAPK pathway are often limited by lack of durable clinical responses or, in many cancer types, lack of even initial responses. While great headway has been made on characterizing mechanisms of resistance, understanding the full influence of complex intercellular interactions on drug resistance remains a challenge. Here, we combine computation with experiment to investigate the cellular and molecular contributions of the tumor microenvironment to MAPK inhibitor response. First, we employ a computational framework using published bulk and single-cell patient gene expression data to investigate immune cell correlates of MAPK inhibitor resistance, and subsequently quantify potential intercellular ligand-receptor interactions between cell populations of interest. Next, we use multiplex proteomic immunoassays and co-culture experiments to characterize the impact of these interactions on tumor-intrinsic bypass signaling and phenotype. To assess the in vivo relevance of these multicellular and multidirectional signaling networks, we develop an intravital imaging strategy to monitor the influence of tumor-associated macrophages on cancer cell kinase activity dynamics. Finally, we rationally design a nanotherapy to exploit inhibitor-induced immunomodulation and crosstalk. Overall, we present a paradigm to systematically dissect signaling pathways between tumors and their microenvironments, validate these interactions in various models of disease, and design therapeutic strategies to target them.

Degree

thesis:*
Name thesis:degree_name
Doctoral
Department dc:contributor.department
Massachusetts Institute of Technology. Department of Biological Engineering
Grantor dc:publisher
Massachusetts Institute of Technology
Year dc:date.issued
2019

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Wang, Stephanie Joy.
Advisor dc:contributor.advisor
  • Douglas A. Lauffenburger.

Subjects

dc:subject × 1

Rights

dc:rights
Statement dc:rights
  • MIT theses are protected by copyright. They may be viewed, downloaded, or printed from this source but further reproduction or distribution in any format is prohibited without written permission.
Language dc:language.iso
eng

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/1721.1/123068
OAI identifier oai:identifier
oai:dspace.mit.edu:1721.1/123068

Chain of custody

source
Harvested from
MIT
Base URL
dspace.mit.edu/oai/request
Last updated
2026-07-22
Source record
OAI-PMH GetRecord
citation

Wang, Stephanie Joy.. Macrophage-mediated resistance mechanisms against MAPK inhibitory by cancer therapeutics. Massachusetts Institute of Technology, 2019. https://hdl.handle.net/1721.1/123068